A recent study found that fecal microbiota-based screening may help detect early-stage pancreatic cancer.
Researchers reported that fecal metagenomic classifiers performed significantly better than saliva-based classifiers in identifying patients with pancreatic ductal adenocarcinoma. It was the top story in gastroenterology last week. Read more in Healio.